• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期帕金森病中深部灰质萎缩和多巴胺可用性的数据驱动亚型的临床相关性。

Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson's disease.

作者信息

Oh Yoonsang, Kim Joong-Seok, Park Gilsoon, Yoo Sang-Won, Ryu Dong-Woo, Kim Hosung

机构信息

Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

NPJ Parkinsons Dis. 2025 Jun 12;11(1):165. doi: 10.1038/s41531-025-01037-5.

DOI:10.1038/s41531-025-01037-5
PMID:40506474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12162818/
Abstract

Recent machine-learning techniques may be useful to identify subtypes with distinct spatial patterns of biomarker abnormality in the various neurodegenerative diseases. Using the Subtype and Stage Inference (SuStaIn) technique, we categorized data-driven subtypes of PD by examining the deep gray matter volume and dopamine availability and compared cardiac denervation, cognition, and motor symptoms between these subtypes. The SuStaIn algorithm revealed two distinctive subtypes, which were well replicated in an external dataset. Subtype 1 was characterized by lower dopamine availability apparent at early inferred stages, severe cardiac denervation, mild cognitive dysfunction in the early stage, and patterns suggesting accelerated motor and cognitive dysfunction associated with later stages. In contrast, subtype 2 showed patterns indicative of earlier brain atrophy, mild cardiac denervation, and severe cognitive dysfunction apparent at early inferred stages, with no significant correlation between motor and cognitive status and SuStaIn stage. These findings suggest that the machine-learning model can identify heterogeneity in PD biomarker profiles, offering insights into potential region and stage-specific patterns of biomarker abnormality and their clinical implications.

摘要

最近的机器学习技术可能有助于识别各种神经退行性疾病中具有不同生物标志物异常空间模式的亚型。使用亚型和阶段推断(SuStaIn)技术,我们通过检查深部灰质体积和多巴胺可用性对数据驱动的帕金森病亚型进行了分类,并比较了这些亚型之间的心脏去神经支配、认知和运动症状。SuStaIn算法揭示了两种不同的亚型,这在外部数据集中得到了很好的重复。亚型1的特征是在早期推断阶段多巴胺可用性较低,严重的心脏去神经支配,早期轻度认知功能障碍,以及与后期相关的运动和认知功能障碍加速模式。相比之下,亚型2显示出早期脑萎缩、轻度心脏去神经支配以及在早期推断阶段明显的严重认知功能障碍的模式,运动和认知状态与SuStaIn阶段之间无显著相关性。这些发现表明,机器学习模型可以识别帕金森病生物标志物谱中的异质性,为生物标志物异常的潜在区域和阶段特异性模式及其临床意义提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/0a5bc48f9f8a/41531_2025_1037_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/102136a57a69/41531_2025_1037_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/64f097368418/41531_2025_1037_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/0a5bc48f9f8a/41531_2025_1037_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/102136a57a69/41531_2025_1037_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/64f097368418/41531_2025_1037_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea6/12162818/0a5bc48f9f8a/41531_2025_1037_Fig3_HTML.jpg

相似文献

1
Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson's disease.早期帕金森病中深部灰质萎缩和多巴胺可用性的数据驱动亚型的临床相关性。
NPJ Parkinsons Dis. 2025 Jun 12;11(1):165. doi: 10.1038/s41531-025-01037-5.
2
Neuroanatomical heterogeneity drives divergent cognitive and motor trajectories in Parkinson's disease subtypes.神经解剖学异质性驱动帕金森病亚型中不同的认知和运动轨迹。
J Neurol Sci. 2025 Jan 15;468:123335. doi: 10.1016/j.jns.2024.123335. Epub 2024 Dec 2.
3
Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.帕金森病相关认知障碍中多巴胺可利用度和深部灰质体积的时空进展模式。
Neurology. 2024 Jul 23;103(2):e209498. doi: 10.1212/WNL.0000000000209498. Epub 2024 Jun 17.
4
Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.帕金森病中脑萎缩三个不同时空模式的描绘。
Brain. 2024 Nov 4;147(11):3702-3713. doi: 10.1093/brain/awae303.
5
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.不同的脑萎缩进展亚型是孤立性快速眼动睡眠行为障碍中表型转换的基础。
EBioMedicine. 2025 May 29;117:105753. doi: 10.1016/j.ebiom.2025.105753.
6
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.ALS-FTD 谱中的新型数据驱动型脑萎缩亚型和分期。
Transl Neurodegener. 2023 Dec 7;12(1):57. doi: 10.1186/s40035-023-00389-3.
7
Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.利用基于多模态数据的亚型揭示帕金森病异质性。
Parkinsonism Relat Disord. 2022 Sep;102:19-29. doi: 10.1016/j.parkreldis.2022.07.014. Epub 2022 Jul 30.
8
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.肌萎缩侧索硬化症-额颞叶痴呆谱系中脑萎缩的新型数据驱动亚型和阶段
Res Sq. 2023 Aug 10:rs.3.rs-3183113. doi: 10.21203/rs.3.rs-3183113/v1.
9
Nuclear Imaging Data-Driven Classification of Parkinson's Disease.核医学成像数据驱动的帕金森病分类。
Mov Disord. 2023 Nov;38(11):2053-2063. doi: 10.1002/mds.29582. Epub 2023 Aug 28.
10
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.帕金森病亚型的临床标准:生物标志物和纵向进展。
Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.

本文引用的文献

1
Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.帕金森病中脑萎缩三个不同时空模式的描绘。
Brain. 2024 Nov 4;147(11):3702-3713. doi: 10.1093/brain/awae303.
2
Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.帕金森病相关认知障碍中多巴胺可利用度和深部灰质体积的时空进展模式。
Neurology. 2024 Jul 23;103(2):e209498. doi: 10.1212/WNL.0000000000209498. Epub 2024 Jun 17.
3
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
帕金森病的心脏123I-间碘苄胍(MIBG)闪烁扫描术:一项综述
Brain Sci. 2023 Oct 18;13(10):1471. doi: 10.3390/brainsci13101471.
4
Two distinct trajectories of clinical and neurodegeneration events in Parkinson's disease.帕金森病临床和神经退行性变事件的两种不同轨迹。
NPJ Parkinsons Dis. 2023 Jul 13;9(1):111. doi: 10.1038/s41531-023-00556-3.
5
The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment.用于综合神经心理学评估的首尔神经心理学筛查量表(SNSB)。
Dement Neurocogn Disord. 2023 Jan;22(1):1-15. doi: 10.12779/dnd.2023.22.1.1. Epub 2023 Jan 27.
6
Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts.在两个队列中使用机器学习识别和预测帕金森病的亚型及进展
NPJ Parkinsons Dis. 2022 Dec 16;8(1):172. doi: 10.1038/s41531-022-00439-z.
7
Comparison of disease progression between brain-predominant Parkinson's disease versus Parkinson's disease with body-involvement phenotypes.脑型帕金森病与伴有全身症状的帕金森病的疾病进展比较。
Neurobiol Dis. 2022 Nov;174:105883. doi: 10.1016/j.nbd.2022.105883. Epub 2022 Oct 5.
8
Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease.额眶部和边缘系统对帕金森病认知下降的贡献。
J Neuroimaging. 2023 Jan;33(1):121-133. doi: 10.1111/jon.13045. Epub 2022 Sep 6.
9
Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes.脑型和体型优先帕金森病亚型的灰质体积损失。
Mov Disord. 2022 Oct;37(10):2066-2074. doi: 10.1002/mds.29172. Epub 2022 Aug 9.
10
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.基于人群的机器学习研究:识别和预测肌萎缩侧索硬化临床亚组。
Lancet Digit Health. 2022 May;4(5):e359-e369. doi: 10.1016/S2589-7500(21)00274-0. Epub 2022 Mar 24.